Replies to post #10098 on ANI Pharmaceuticals (ANIP)

[jacob613]

Art isn't going to include Cort in guidance. So what happens if generics quarter was bad and outlook flat but he maintains bullish $200mm cash flow on Cort? Stock down 10%. Hard to stomach a down 20% again...praying not